Brief: Tenax Therapeutics Q4 Net Income USD -15.54 Million
Mar 10 (Reuters) - Tenax Therapeutics Q4 operating expenses USD 16.449 million. Q4 operating income USD -16.449 million
Mar 10 (Reuters) - Tenax Therapeutics Q4 operating expenses USD 16.449 million. Q4 operating income USD -16.449 million